Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""International journal of cancer [Int J Cancer] NLMUID: 0042124"" wg kryterium: JN


Tytuł :
Impact of Human Papillomavirus on the Tumor Microenvironment in Oropharyngeal Squamous Cell Carcinoma.
Autorzy :
Liu X; Department of Pharmacology and Regenerative Medicine, University of Illinois at Chicago.; University of Illinois Cancer Center, Chicago, IL.
Liu P; Department of Radiation Oncology.
Chernock RD; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO.
Lang Kuhs KA; Department of Epidemiology, College of Public Health, University of Kentucky, Lexington, KY.
Lewis JS Jr; Department of Otolaryngology - Head and Neck Surgery.; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN.
Li H; Department of Bioengineering, University of Illinois at Urbana-Champaign, Urbana, IL.; Carle Foundation Hospital, Urbana, IL.; Cancer Center at Illinois, Urbana, IL.
Gay HA; Department of Radiation Oncology.
Thorstad WL; Department of Radiation Oncology.
Wang X; Department of Pharmacology and Regenerative Medicine, University of Illinois at Chicago.; University of Illinois Cancer Center, Chicago, IL.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2021 Oct 16. Date of Electronic Publication: 2021 Oct 16.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Oncogenic potential of human pluripotent stem cell-derived lung organoids with HER2 overexpression.
Autorzy :
Miura A; Department of Regenerative Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.; Department of General Thoracic Surgery and Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Yamada D; Department of Regenerative Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Nakamura M; Precision Health, Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, Tokyo, Japan.
Tomida S; Center for Comprehensive Genomic Medicine, Okayama University Hospital, Okayama, Japan.
Shimizu D; Department of Regenerative Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.; Department of General Thoracic Surgery and Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Jiang Y; Department of Regenerative Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Takao T; Department of Regenerative Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Yamamoto H; Department of General Thoracic Surgery and Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Suzawa K; Department of General Thoracic Surgery and Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Shien K; Department of General Thoracic Surgery and Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Yamane M; Department of General Thoracic Surgery and Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Sakaguchi M; Department of Cell Biology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Toyooka S; Department of General Thoracic Surgery and Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Takarada T; Department of Regenerative Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2021 Oct 15; Vol. 149 (8), pp. 1593-1604. Date of Electronic Publication: 2021 Jul 07.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinogenesis*
Gene Expression Regulation, Neoplastic*
Adenocarcinoma of Lung/*pathology
Induced Pluripotent Stem Cells/*pathology
Lung Neoplasms/*pathology
Organoids/*pathology
Receptor, ErbB-2/*metabolism
Adenocarcinoma of Lung/genetics ; Adenocarcinoma of Lung/metabolism ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Cell Differentiation ; Humans ; Induced Pluripotent Stem Cells/metabolism ; Lung Neoplasms/genetics ; Lung Neoplasms/metabolism ; Organoids/metabolism ; Receptor, ErbB-2/genetics ; Transcriptome ; Tumor Cells, Cultured
Czasopismo naukowe
Tytuł :
Axillary response according to neoadjuvant single or dual human epidermal growth factor receptor 2 (HER2) blockade in clinically node-positive, HER2-positive breast cancer.
Autorzy :
Cha C; Department of Surgery, Hanyang University College of Medicine, Seoul, South Korea.
Ahn SG; Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.; Institute for Breast Cancer Precision Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Kim D; Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
Lee J; Department of Surgery, Dongtan Sacred Heart Hospital, Hallym University, Hwaseong, South Korea.
Park S; Department of Surgery, CHA Ilsan Medical Center, CHA University School of Medicine, Goyang-si, South Korea.
Bae SJ; Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.; Institute for Breast Cancer Precision Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Kim JY; Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
Park HS; Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
Park S; Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
Kim SI; Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
Park BW; Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
Jeong J; Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.; Institute for Breast Cancer Precision Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2021 Oct 15; Vol. 149 (8), pp. 1585-1592. Date of Electronic Publication: 2021 Jul 08.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Breast Neoplasms/*drug therapy
Lymph Nodes/*pathology
Neoadjuvant Therapy/*methods
Receptor, ErbB-2/*antagonists & inhibitors
Receptor, ErbB-2/*metabolism
Adult ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal, Humanized/administration & dosage ; Axilla ; Biomarkers, Tumor ; Breast Neoplasms/metabolism ; Breast Neoplasms/pathology ; Female ; Follow-Up Studies ; Gene Expression Regulation, Neoplastic ; Humans ; Lymph Nodes/metabolism ; Lymphatic Metastasis ; Middle Aged ; Prognosis ; Retrospective Studies ; Survival Rate ; Trastuzumab/administration & dosage
Czasopismo naukowe
Tytuł :
Outcome of the randomized control screening trials on oral, cervix and breast cancer from India and way forward in COVID-19 pandemic situation.
Autorzy :
Budukh AM; Centre for Cancer Epidemiology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
Dikshit R; Centre for Cancer Epidemiology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
Chaturvedi P; Centre for Cancer Epidemiology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2021 Oct 15; Vol. 149 (8), pp. 1619-1620. Date of Electronic Publication: 2021 Jun 30.
Typ publikacji :
Letter
MeSH Terms :
Breast Neoplasms/*diagnosis
COVID-19/*epidemiology
Early Detection of Cancer/*statistics & numerical data
Mouth Neoplasms/*diagnosis
Randomized Controlled Trials as Topic/*methods
SARS-CoV-2/*isolation & purification
Uterine Cervical Neoplasms/*diagnosis
Breast Neoplasms/epidemiology ; COVID-19/complications ; COVID-19/virology ; Female ; Humans ; India/epidemiology ; Mouth Neoplasms/epidemiology ; Prognosis ; Uterine Cervical Neoplasms/epidemiology
Opinia redakcyjna
Tytuł :
Chronic viral hepatitis, HIV infection and Non-Hodgkin lymphomas in West Africa, a case-control study.
Autorzy :
Jaquet A; University of Bordeaux, Inserm, French National Research Institute for Sustainable Development (IRD), Bordeaux, France.
Boni SP; Programme National de Lutte Contre le Cancer (PNLCa), Abidjan, Côte d'Ivoire.; Programme PACCI/Site ANRS Abidjan, Abidjan, Côte d'Ivoire.
Boidy K; Service d'hématologie, Centre Hospitalier Universitaire de Yopougon, Abidjan, Côte d'Ivoire.
Tine J; Service des Maladies Infectieuses et Tropicales, Centre Hospitalier National Universitaire de Fann, Dakar, Senegal.
Tchounga B; Programme PACCI/Site ANRS Abidjan, Abidjan, Côte d'Ivoire.; Elizabeth Glaser Pediatric AIDS Foundation, Yaoundé, Cameroon.
Touré SA; Service d'hématologie, Centre National de Transfusion Sanguine, Dakar, Senegal.
Koffi JJ; Programme PACCI/Site ANRS Abidjan, Abidjan, Côte d'Ivoire.
Dial C; Service Anatomopathologie, Hôpital de Grand Yoff, Dakar, Senegal.
Monnereau A; University of Bordeaux, Inserm, French National Research Institute for Sustainable Development (IRD), Bordeaux, France.
Diomande I; Service Anatomopathologie, Centre Hospitalier Universitaire Cocody, Abidjan, Côte d'Ivoire.
Tanon A; Service des Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire de Treichville, Abidjan, Côte d'Ivoire.
Seydi M; Service des Maladies Infectieuses et Tropicales, Centre Hospitalier National Universitaire de Fann, Dakar, Senegal.
Dabis F; University of Bordeaux, Inserm, French National Research Institute for Sustainable Development (IRD), Bordeaux, France.
Diop S; Service d'hématologie, Centre National de Transfusion Sanguine, Dakar, Senegal.
Koffi G; Service d'hématologie, Centre Hospitalier Universitaire de Yopougon, Abidjan, Côte d'Ivoire.
Pokaż więcej
Corporate Authors :
IeDEA West Africa Collaboration
Źródło :
International journal of cancer [Int J Cancer] 2021 Oct 15; Vol. 149 (8), pp. 1536-1543. Date of Electronic Publication: 2021 Jun 19.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
HIV/*isolation & purification
HIV Infections/*complications
Hepatitis B virus/*isolation & purification
Hepatitis B, Chronic/*complications
Lymphoma, Non-Hodgkin/*epidemiology
Adult ; Africa, Western/epidemiology ; Case-Control Studies ; Female ; Follow-Up Studies ; HIV Infections/virology ; Hepatitis B, Chronic/virology ; Humans ; Lymphoma, Non-Hodgkin/virology ; Male ; Middle Aged ; Prognosis
Czasopismo naukowe
Tytuł :
Colorectal cancer survival in sub-Saharan Africa by age, stage at diagnosis and Human Development Index: A population-based registry study.
Autorzy :
Gullickson C; Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.; Emory University School of Medicine, Atlanta, Georgia, USA.
Goodman M; Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
Joko-Fru YW; The African Cancer Registry Network, INCTR African Registry Programme, Oxford, UK.; Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Gnangnon FHR; Cotonou Cancer Registry, Cotonou, Benin.; Department of Visceral Surgery, School of Medicine, University of Abomey-Calavi, Benin.
N'Da G; Abidjan Cancer Registry, Abidjan, Côte d'Ivoire.
Woldegeorgis MA; Addis Ababa City Cancer Registry, Addis Ababa, Ethiopia.
Buziba NG; Eldoret Cancer Registry, Eldoret, Kenya.
Karugu C; Nairobi Cancer Registry, Nairobi, Kenya.
Manraj SS; Mauritius National Cancer Registry, Port Louis, Mauritius.
Lorenzoni CF; Maputo Cancer Registry, Maputo, Mozambique.
Hansen R; Namibian Cancer Registry, Windhoek, Namibia.
Finesse A; Seychelles National Cancer Registry, Victoria, Seychelles.
Somdyala NIM; Eastern Cape Cancer Registry, South African Medical Research Council, Tygerberg, South Africa.
Bukirwa P; Kampala Cancer Registry, Kampala, Uganda.
Chingonzoh T; Bulawayo Cancer Registry, Bulawayo, Zimbabwe.
Chokunonga E; Zimbabwe National Cancer Registry, Harare, Zimbabwe.
Liu B; The African Cancer Registry Network, INCTR African Registry Programme, Oxford, UK.
Kantelhardt E; Institute of Medical Epidemiology, Biostatistics and Informatics, Martin Luther University Halle-Wittenberg, Halle, Germany.; Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle, Germany.
Parkin DM; The African Cancer Registry Network, INCTR African Registry Programme, Oxford, UK.; Nuffield Department of Population Health, University of Oxford, Oxford, UK.; Cancer Surveillance Unit, International Agency for Research on Cancer, Lyon, France.
Jemal A; American Cancer Society, Atlanta, Georgia, USA.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2021 Oct 15; Vol. 149 (8), pp. 1553-1563. Date of Electronic Publication: 2021 Jul 21.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Colorectal Neoplasms/*mortality
Registries/*statistics & numerical data
Africa South of the Sahara/epidemiology ; Age Factors ; Aged ; Colorectal Neoplasms/diagnosis ; Colorectal Neoplasms/epidemiology ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Neoplasm Staging ; Survival Rate
Czasopismo naukowe
Tytuł :
Association of bowel movement frequency and laxative use with risk of hepatocellular carcinoma in US women and men.
Autorzy :
Long L; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Department of Epidemiology and Biostatistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.
Liu X; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Department of Epidemiology, School of Public Health, Fudan University, Shanghai, China.
Jin L; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Department of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, China.
Simon T; Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Clinical and Translational Epidemiology Unit (CTEU), Massachusetts General Hospital, Boston, Massachusetts, USA.
Ma W; Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Clinical and Translational Epidemiology Unit (CTEU), Massachusetts General Hospital, Boston, Massachusetts, USA.
Kim MN; Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Clinical and Translational Epidemiology Unit (CTEU), Massachusetts General Hospital, Boston, Massachusetts, USA.; Division of Gastroenterology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, South Korea.
Yang W; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Department of Nutrition, School of Public Health, Anhui Medical University, Hefei, Anhui, China.
Meyerhardt JA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.
Chan AT; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Giovannucci E; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Zhang X; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2021 Oct 15; Vol. 149 (8), pp. 1529-1535. Date of Electronic Publication: 2021 Jun 04.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Gastrointestinal Motility*
Carcinoma, Hepatocellular/*pathology
Laxatives/*adverse effects
Liver Neoplasms/*pathology
Adult ; Aged ; Carcinoma, Hepatocellular/epidemiology ; Carcinoma, Hepatocellular/etiology ; Female ; Follow-Up Studies ; Humans ; Liver Neoplasms/epidemiology ; Liver Neoplasms/etiology ; Male ; Middle Aged ; Prognosis ; Prospective Studies ; Risk Factors ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Risk of epithelial ovarian cancer Type I and II after hysterectomy, salpingectomy and tubal ligation-A nationwide case-control study.
Autorzy :
Darelius A; Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Gynecology and Reproductive Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
Kristjansdottir B; Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Gynecology and Reproductive Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
Dahm-Kähler P; Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Gynecology and Reproductive Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
Strandell A; Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Gynecology and Reproductive Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2021 Oct 15; Vol. 149 (8), pp. 1544-1552. Date of Electronic Publication: 2021 Jul 07.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinoma, Ovarian Epithelial/*pathology
Hysterectomy/*adverse effects
Ovarian Neoplasms/*pathology
Salpingectomy/*adverse effects
Sterilization, Tubal/*adverse effects
Aged ; Carcinoma, Ovarian Epithelial/classification ; Carcinoma, Ovarian Epithelial/etiology ; Case-Control Studies ; Female ; Follow-Up Studies ; Humans ; Middle Aged ; Ovarian Neoplasms/classification ; Ovarian Neoplasms/etiology ; Prognosis ; Retrospective Studies ; Risk Factors
Czasopismo naukowe
Tytuł :
Oligometastatic breast cancer: Are we there yet?
Autorzy :
AlSendi M; Medical Oncology Department, Mater Misericordiae University Hospital, Dublin, Ireland.
O'Reilly D; Medical Oncology Department, Mater Misericordiae University Hospital, Dublin, Ireland.
Zeidan YH; Department of Radiation Oncology, American University of Beirut, Beirut, Lebanon.
Kelly CM; Medical Oncology Department, Mater Misericordiae University Hospital, Dublin, Ireland.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2021 Oct 15; Vol. 149 (8), pp. 1520-1528. Date of Electronic Publication: 2021 Jun 08.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Breast Neoplasms/*pathology
Breast Neoplasms/*therapy
Combined Modality Therapy ; Female ; Humans ; Neoplasm Metastasis
Czasopismo naukowe
Tytuł :
Modelling the impact of prevention strategies on cervical cancer incidence in South Africa.
Autorzy :
van Schalkwyk C; The South African Department of Science and Innovation/National Research Foundation Centre of Excellence in Epidemiological Modelling and Analysis, Stellenbosch University, Stellenbosch, South Africa.
Moodley J; Women's Health Research Unit, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.; Cancer Research Initiative, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; South African Medical Research Council Gynaecology Cancer Research Centre, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Welte A; The South African Department of Science and Innovation/National Research Foundation Centre of Excellence in Epidemiological Modelling and Analysis, Stellenbosch University, Stellenbosch, South Africa.
Johnson LF; Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2021 Oct 15; Vol. 149 (8), pp. 1564-1575. Date of Electronic Publication: 2021 Jul 19.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Models, Statistical*
Alphapapillomavirus/*drug effects
HIV/*drug effects
HIV Infections/*prevention & control
Papillomavirus Infections/*prevention & control
Uterine Cervical Neoplasms/*epidemiology
AIDS Vaccines/administration & dosage ; Adult ; Aged ; Alphapapillomavirus/isolation & purification ; Early Detection of Cancer/methods ; Female ; Follow-Up Studies ; HIV/isolation & purification ; HIV Infections/complications ; HIV Infections/virology ; Humans ; Incidence ; Middle Aged ; Papillomavirus Infections/complications ; Papillomavirus Infections/virology ; Papillomavirus Vaccines/administration & dosage ; Prognosis ; South Africa/epidemiology ; Uterine Cervical Neoplasms/diagnosis ; Uterine Cervical Neoplasms/virology ; Young Adult
Czasopismo naukowe
Tytuł :
Toxicity of pemetrexed during renal impairment explained-Implications for safe treatment.
Autorzy :
Boosman RJ; Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek-The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Dorlo TPC; Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek-The Netherlands Cancer Institute, Amsterdam, The Netherlands.
de Rouw N; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Pharmacy, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands.
Burgers JA; Department of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Dingemans AC; Department of Pulmonary Diseases, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.; Department of Pulmonology, Erasmus MC, Rotterdam, The Netherlands.
van den Heuvel MM; Department of Pulmonology, Radboud university medical center, Nijmegen, The Netherlands.
Hendriks LEL; Department of Pulmonary Diseases, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.
Biesma B; Department of Pulmonary Diseases, Jeroen Bosch Hospital, 's Hertogenbosch, The Netherlands.
Aerts JGJV; Department of Pulmonology, Erasmus MC, Rotterdam, The Netherlands.
Croes S; Department of Clinical Pharmacy & Toxicology, Maastricht University Medical Centre, Maastricht, The Netherlands.
Mathijssen RHJ; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.
Huitema ADR; Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek-The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Clinical Pharmacy, Utrecht University Medical Center, Utrecht University, Utrecht, The Netherlands.; Department of Pharmacology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Ter Heine R; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2021 Oct 15; Vol. 149 (8), pp. 1576-1584. Date of Electronic Publication: 2021 Jul 07.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Non-Small-Cell Lung/*drug therapy
Folic Acid Antagonists/*adverse effects
Kidney Failure, Chronic/*chemically induced
Lung Neoplasms/*drug therapy
Neutropenia/*chemically induced
Pemetrexed/*adverse effects
Adult ; Aged ; Aged, 80 and over ; Carcinoma, Non-Small-Cell Lung/pathology ; Clinical Trials, Phase I as Topic ; Clinical Trials, Phase II as Topic ; Dietary Supplements ; Dose-Response Relationship, Drug ; Female ; Folic Acid Antagonists/administration & dosage ; Folic Acid Antagonists/pharmacokinetics ; Follow-Up Studies ; Humans ; Kidney Failure, Chronic/epidemiology ; Kidney Failure, Chronic/prevention & control ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Neutropenia/epidemiology ; Neutropenia/prevention & control ; Pemetrexed/administration & dosage ; Pemetrexed/pharmacokinetics ; Prognosis ; Tissue Distribution
Czasopismo naukowe
Tytuł :
Serum glial fibrillary acidic protein is a predictor of brain metastases in patients with metastatic breast cancer.
Autorzy :
Darlix A; Department of Medical Oncology, University of Montpellier, Institut régional du Cancer de Montpellier, Montpellier, France.; Institut de Génomique Fonctionnelle, CNRS, INSERM, University of Montpellier, Montpellier, France.
Hirtz C; LBPC-PPC, University of Montpellier, CHU Montpellier, INSERM, Montpellier, France.
Mollevi C; Biometrics Unit, University of Montpellier, Institut regional du Cancer de Montpellier, Montpellier, France.; UA11 Institut Desbrest d'Epidémiologie et de Santé Publique, INSERM, University of Montpellier, Montpellier, France.
Ginestet N; LBPC-PPC, University of Montpellier, CHU Montpellier, INSERM, Montpellier, France.
Tiers L; LBPC-PPC, University of Montpellier, CHU Montpellier, INSERM, Montpellier, France.
Jacot W; Department of Medical Oncology, University of Montpellier, Institut régional du Cancer de Montpellier, Montpellier, France.
Lehmann S; LBPC-PPC, University of Montpellier, CHU Montpellier, INSERM, Montpellier, France.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2021 Oct 15; Vol. 149 (8), pp. 1605-1618. Date of Electronic Publication: 2021 Jul 19.
Typ publikacji :
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Biomarkers, Tumor/*blood
Brain Neoplasms/*secondary
Breast Neoplasms/*pathology
Glial Fibrillary Acidic Protein/*blood
Adult ; Brain Neoplasms/blood ; Brain Neoplasms/therapy ; Breast Neoplasms/blood ; Breast Neoplasms/therapy ; Combined Modality Therapy ; Female ; Follow-Up Studies ; Humans ; Middle Aged ; Prognosis ; ROC Curve ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł :
A European, prospective, observational study of enzalutamide in patients with metastatic castration-resistant prostate cancer: PREMISE.
Autorzy :
Payne H; Department of Oncology, University College Hospital, London, UK.
Robinson A; Sussex Cancer Centre, Royal Sussex County Hospital, Brighton, UK.
Rappe B; Department of Urology, ASZ Aalst, Aalst, Belgium.
Hilman S; Department of Oncology, Weston General Hospital, Weston-super-Mare, UK.
De Giorgi U; Department of Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
Joniau S; Department of Urology, University Hospitals Leuven, Leuven, Belgium.
Bordonaro R; Garibaldi Nesima Hospital, Catania, Italy.
Mallick S; Department of Urology, Saint-Michel Clinic, Toulon, France.
Dourthe LM; Department of Medical Oncology, Saint Anne Clinic, Strasbourg, France.
Flores MM; Department of Radiotherapy Oncology, Arnau de Vilanova University Hospital, Lleida, Spain.
Gumà J; Oncology Institute of Southern Catalonia, Sant Joan University Hospital, IISPV, URV, Reus, Spain.
Baron B; Astellas Pharma Inc., Leiden, the Netherlands.
Duran A; Astellas Pharma Europe Ltd., Weybridge, UK.
Pranzo A; Astellas Pharma Europe Ltd., Weybridge, UK.
Serikoff A; Astellas Pharma, Levallois-Perret, France.
Mott D; Office of Health Economics, London, UK.
Herdman M; Office of Health Economics, London, UK.
Pavesi M; Data Center, European Foundation for the Study of Chronic Liver Failure, Barcelona, Spain, and Office of Health Economics, London, UK.
De Santis M; Department of Urology, Charité University Hospital, Berlin, Germany, and Medical University of Vienna, Vienna, Austria.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2021 Oct 14. Date of Electronic Publication: 2021 Oct 14.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Parity is associated with better prognosis in ovarian germ cell tumors, but not in other ovarian cancer subtypes.
Autorzy :
Sköld C; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Koliadi A; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Enblad G; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Stålberg K; Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
Glimelius I; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.; Department of Medicine, Division of Clinical Epidemiology, Karolinska Institutet, Stockholm, Sweden.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2021 Oct 14. Date of Electronic Publication: 2021 Oct 14.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Prognostic Value of GILT Expression in Female Patients Diagnosed with Breast Cancer.
Autorzy :
Ye C; School of Medicine, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.; Department of Breast Surgery, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
Zhou W; Department of Breast Surgery, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.; Institute of Translational Medicine of Breast Disease Prevention and Treatment, Shandong University, Jinan, Shandong, China.; Engineering laboratory of translational research on prevention and treatment of breast disease, Shandong Province, Jinan, Shandong, China.
Wang F; Department of Breast Surgery, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.; Institute of Translational Medicine of Breast Disease Prevention and Treatment, Shandong University, Jinan, Shandong, China.; Engineering laboratory of translational research on prevention and treatment of breast disease, Shandong Province, Jinan, Shandong, China.
Yin G; School of Medicine, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.; Department of Breast Surgery, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
Zhang X; Department of Thyroid and Breast Surgery, Linyi People's Hospital, Linyi, Shandong, China.
Kong L; Department of Breast Surgery, Linyi Cancer Hospital, Linyi, Shandong, China.
Gao Z; Department of Thyroid and Breast Surgery, Linyi People's Hospital, Linyi, Shandong, China.
Feng M; Department of Pathology, The Third Affiliated Hospital of Shandong First Medical University, Jinan, Shandong, China.
Zhou C; Department of Pathology, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
Sun D; Cancer Center, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Wang L; Department of Oncology, Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
Liu L; Department of Breast Surgery, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.; Institute of Translational Medicine of Breast Disease Prevention and Treatment, Shandong University, Jinan, Shandong, China.; Engineering laboratory of translational research on prevention and treatment of breast disease, Shandong Province, Jinan, Shandong, China.
Zheng C; Department of Breast Surgery, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.; Institute of Translational Medicine of Breast Disease Prevention and Treatment, Shandong University, Jinan, Shandong, China.; Engineering laboratory of translational research on prevention and treatment of breast disease, Shandong Province, Jinan, Shandong, China.
Xiang Y; Department of Breast Surgery, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.; Institute of Translational Medicine of Breast Disease Prevention and Treatment, Shandong University, Jinan, Shandong, China.; Engineering laboratory of translational research on prevention and treatment of breast disease, Shandong Province, Jinan, Shandong, China.
Guo M; Department of Breast Surgery, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.; Institute of Translational Medicine of Breast Disease Prevention and Treatment, Shandong University, Jinan, Shandong, China.; Engineering laboratory of translational research on prevention and treatment of breast disease, Shandong Province, Jinan, Shandong, China.
Huang S; School of Medicine, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.; Department of Breast Surgery, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.; Institute of Translational Medicine of Breast Disease Prevention and Treatment, Shandong University, Jinan, Shandong, China.; Engineering laboratory of translational research on prevention and treatment of breast disease, Shandong Province, Jinan, Shandong, China.
Yu Z; Department of Breast Surgery, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.; Institute of Translational Medicine of Breast Disease Prevention and Treatment, Shandong University, Jinan, Shandong, China.; Engineering laboratory of translational research on prevention and treatment of breast disease, Shandong Province, Jinan, Shandong, China.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2021 Oct 14. Date of Electronic Publication: 2021 Oct 14.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Tumor DNA-Methylome derived Epigenetic Fingerprint Identifies HPV-negative Head and Neck Patients at Risk for Locoregional Recurrence after Postoperative Radiochemotherapy.
Autorzy :
Tawk B; German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK), Core Center Heidelberg, Germany.; Clinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Molecular and Translational Radiation Oncology, Department of Radiation Oncology, Heidelberg Faculty of Medicine (MFHD) and Heidelberg University Hospital (UKHD), Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Oncology (NCRO), Heidelberg University and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Wirkner U; German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK), Core Center Heidelberg, Germany.; Clinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Molecular and Translational Radiation Oncology, Department of Radiation Oncology, Heidelberg Faculty of Medicine (MFHD) and Heidelberg University Hospital (UKHD), Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Oncology (NCRO), Heidelberg University and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Schwager C; German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK), Core Center Heidelberg, Germany.; Clinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Molecular and Translational Radiation Oncology, Department of Radiation Oncology, Heidelberg Faculty of Medicine (MFHD) and Heidelberg University Hospital (UKHD), Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Oncology (NCRO), Heidelberg University and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Rein K; German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK), Core Center Heidelberg, Germany.; Clinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Molecular and Translational Radiation Oncology, Department of Radiation Oncology, Heidelberg Faculty of Medicine (MFHD) and Heidelberg University Hospital (UKHD), Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Oncology (NCRO), Heidelberg University and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Zaoui K; Department of Otorhinolaryngology, Head and Neck Surgery, Heidelberg University Hospital, Heidelberg, Germany.
Federspil PA; Department of Otorhinolaryngology, Head and Neck Surgery, Heidelberg University Hospital, Heidelberg, Germany.
Adeberg S; German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK), Core Center Heidelberg, Germany.; Department of Radiation Oncology, University Hospital Heidelberg, Germany; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany; National Center for Tumor diseases (NCT), Heidelberg, Germany.
Linge A; German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK), partner site Dresden, Germany.; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Dresden, Germany.; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany, and; Helmholtz Association / Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.
Ganswindt U; German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK), partner site Munich, Germany.; Department of Radiation Oncology, Medical University of Innsbruck, Innsbruck, Austria.
Hess J; Department of Radiation Oncology, University Hospital Ludwig-Maximilians-University of Munich, Munich, Germany.; Research Unit Radiation Cytogenetics, Helmholtz Zentrum München, German Research Center for Environmental Health GmbH, Neuherberg, Germany.; Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer', Helmholtz Zentrum München, German Research Center for Environmental Health GmbH, Neuherberg, Germany.
Unger K; Department of Radiation Oncology, University Hospital Ludwig-Maximilians-University of Munich, Munich, Germany.; Research Unit Radiation Cytogenetics, Helmholtz Zentrum München, German Research Center for Environmental Health GmbH, Neuherberg, Germany.; Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer', Helmholtz Zentrum München, German Research Center for Environmental Health GmbH, Neuherberg, Germany.
Tinhofer I; German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK), partner site Berlin, Germany.; Department of Radiooncology and Radiotherapy, Charité University Hospital, Berlin, Germany.
Budach V; German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK), partner site Berlin, Germany.; Department of Radiooncology and Radiotherapy, Charité University Hospital, Berlin, Germany.
Lohaus F; German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK), partner site Dresden, Germany.; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Dresden, Germany.; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany, and; Helmholtz Association / Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.
Krause M; German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK), partner site Dresden, Germany.; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Dresden, Germany.; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany, and; Helmholtz Association / Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.
Guberina M; German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK), partner site Essen, Germany.; Department of Radiotherapy, Medical Faculty, University of Duisburg-Essen, Essen, Germany.
Stuschke M; German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK), partner site Essen, Germany.; Department of Radiotherapy, Medical Faculty, University of Duisburg-Essen, Essen, Germany.
Balermpas P; German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK), partner site Frankfurt, Germany.; Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland.
Rödel C; German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK), partner site Frankfurt, Germany.; Department of Radiotherapy and Oncology, Goethe-University Frankfurt, Frankfurt, Germany.
Grosu AL; German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK), partner site Freiburg, Germany.; Department of Radiation Oncology, Clinical Study Section, University of Freiburg, Freiburg, Germany.; Department of Radiation Oncology, University of Freiburg, Freiburg, Germany.
Schäfer H; German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK), partner site Freiburg, Germany.; Department of Radiation Oncology, Clinical Study Section, University of Freiburg, Freiburg, Germany.
Zips D; German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK), partner site Tuebingen, Germany.; Department of Radiation Oncology, Faculty of Medicine and University Hospital Tübingen, Eberhard Karls Universität Tübingen, Germany.
Combs SE; German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK), partner site Munich, Germany.; Department of Radiation Oncology, Technische Universität München, Munich, Germany.
Pigorsch S; German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK), partner site Munich, Germany.; Department of Radiation Oncology, Technische Universität München, Munich, Germany.
Zitzelsberger H; Department of Radiation Oncology, University Hospital Ludwig-Maximilians-University of Munich, Munich, Germany.; Research Unit Radiation Cytogenetics, Helmholtz Zentrum München, German Research Center for Environmental Health GmbH, Neuherberg, Germany.; Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer', Helmholtz Zentrum München, German Research Center for Environmental Health GmbH, Neuherberg, Germany.
Baumeister P; Research Unit Radiation Cytogenetics, Helmholtz Zentrum München, German Research Center for Environmental Health GmbH, Neuherberg, Germany.; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital, Ludwig-Maximilians-University of Munich, Munich, Germany.
Kirchner T; German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK), partner site Munich, Germany.; Institute of Pathology, Faculty of Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany.
Bewerunge-Hudler M; Genomics and Proteomics Core Facility, German Cancer Research Center, Heidelberg, Germany.
Weichert W; German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK), partner site Munich, Germany.; Institute of Pathology, Technische Universität München, Munich, Germany.
Hess J; Department of Otorhinolaryngology, Head and Neck Surgery, Heidelberg University Hospital, Heidelberg, Germany.; Department of Molecular Mechanisms of Head and Neck Tumors, German Cancer Research Center, Heidelberg, Germany.
Herpel E; German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK), Core Center Heidelberg, Germany.; Tissue Bank, National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Department of Applied Tumor Biology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
Belka C; German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK), partner site Munich, Germany.; Department of Radiation Oncology, University Hospital Ludwig-Maximilians-University of Munich, Munich, Germany.; Research Unit Radiation Cytogenetics, Helmholtz Zentrum München, German Research Center for Environmental Health GmbH, Neuherberg, Germany.
Baumann M; German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK), Core Center Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK), partner site Dresden, Germany.; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Dresden, Germany.
Debus J; German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK), Core Center Heidelberg, Germany.; Clinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Molecular and Translational Radiation Oncology, Department of Radiation Oncology, Heidelberg Faculty of Medicine (MFHD) and Heidelberg University Hospital (UKHD), Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Oncology (NCRO), Heidelberg University and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Abdollahi A; German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK), Core Center Heidelberg, Germany.; Clinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Molecular and Translational Radiation Oncology, Department of Radiation Oncology, Heidelberg Faculty of Medicine (MFHD) and Heidelberg University Hospital (UKHD), Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Oncology (NCRO), Heidelberg University and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Pokaż więcej
Corporate Authors :
DKTK-ROG
Źródło :
International journal of cancer [Int J Cancer] 2021 Oct 14. Date of Electronic Publication: 2021 Oct 14.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Neuroblastoma - telomere maintenance, deregulated signalling transduction and beyond.
Autorzy :
Stainczyk SA; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Neuroblastoma Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Westermann F; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Neuroblastoma Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2021 Oct 11. Date of Electronic Publication: 2021 Oct 11.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Age-specific burden of cervical cancer associated with HIV: a global analysis with a focus on sub-Saharan Africa.
Autorzy :
Ibrahim Khalil A; Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Mpunga T; Butaro Cancer Centre of Excellence, Ministry of Health, Butaro, Rwanda.
Wei F; Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Baussano I; Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
de Martel C; Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Bray F; Cancer Surveillance Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Stelzle D; Center for Global Health, Department of Neurology, Faculty of Medicine, Technical University of Munich, Germany.; Chair of Epidemiology, Department of Sport and Health Sciences, Technical University of Munich, Germany.
Dryden-Peterson S; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Jaquet A; University of Bordeaux, Inserm, French National Research Institute for Sustainable Development (IRD), UMR 1219, Bordeaux, France.
Horner MJ; Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.
Awolude OA; Department of Obstetrics and Gynaecology, College of Medicine, University of Ibadan, Ibadan, Nigeria.; Infectious Disease Institute, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Trejo MJ; Department of Epidemiology and Biostatistics, University of Arizona, Tucson, Arizona.
Mudini W; Division of Anatomical Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Soliman AS; Community Health and Social Medicine Department, CUNY School of Medicine, The City College of New York, New York City, New York.
Sengayi-Muchengeti M; National Cancer Registry, National Health Laboratory Service, Johannesburg, South Africa.; School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.; South African DSI-NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, South Africa.
Coghill AE; Cancer Epidemiology Program, Division of Population Science, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
van Aardt MC; Gynaecologic Oncology Unit, Department of Obstetrics and Gynaecology, University of Pretoria, Pretoria, South Africa.
De Vuyst H; Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Hawes SE; Departments of Epidemiology, Health Services, and Global Health, University of Washington, Seattle, Washington.
Broutet N; Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
Dalal S; Department of Global HIV, Hepatitis and STIs Programmes, World Health Organization, Geneva, Switzerland.
Clifford GM
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2021 Oct 09. Date of Electronic Publication: 2021 Oct 09.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Epstein-Barr virus prevalence among subtypes of malignant lymphoma in Rwanda, 2012-2018.
Autorzy :
Mpunga T; Butaro Cancer Center of Excellence, Ministry of Health, Butaro, Rwanda.
Clifford GM; Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Morgan EA; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Milner DA Jr; American Society for Clinical Pathology, Chicago, IL, USA.
de Martel C; Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Munyanshongore C; School of Public Health, University of Rwanda, Kigali, Rwanda.
Muvugabigwi G; Butaro Cancer Center of Excellence, Ministry of Health, Butaro, Rwanda.
Combes JD; Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2021 Oct 09. Date of Electronic Publication: 2021 Oct 09.
Typ publikacji :
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies